National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 70065 [2013-28004]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 226 / Friday, November 22, 2013 / Notices
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 18, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
Dated: November 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28086 Filed 11–21–13; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2013–28004 Filed 11–21–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HOMELAND
SECURITY
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
U.S. Customs and Border Protection
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Mucosal Environment and
HIV Prevention.
Date: December 17–18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, Chevy Chase Ballroom, 4300
Military Road, NW, Washington, DC 20015.
Contact Person: Roberta Binder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3130, Bethesda, MD
20892–7616, 301–496–7966, rbinder@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Innovation for HIV Vaccine
Discovery.
Date: December 18, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Sujata Vijh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–594–
0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
VerDate Mar<15>2010
16:47 Nov 21, 2013
Jkt 232001
Agency Information Collection
Activities: Customs Declaration
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security
ACTION: 60-Day notice and request for
comments; Extension of an existing
collection of information: 1651–0009.
AGENCY:
As part of its continuing effort
to reduce paperwork and respondent
burden, CBP invites the general public
and other Federal agencies to comment
on an information collection
requirement concerning the Customs
Declaration. This request for comment is
being made pursuant to the Paperwork
Reduction Act of 1995 (Pub. L. 104–13).
DATES: Written comments should be
received on or before January 21, 2014
to be assured of consideration.
ADDRESSES: Direct all written comments
to U.S. Customs and Border Protection,
Attn: Tracey Denning, Regulations and
Rulings, Office of International Trade,
90 K Street NE., 10th Floor, Washington,
DC 20229–1177.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Tracey Denning,
U.S. Customs and Border Protection,
Regulations and Rulings, Office of
International Trade, 90 K Street NE.,
10th Floor, Washington, DC 20229–
1177, at 202–325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L. 104–13).
The comments should address: (a)
Whether the collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimates of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; (d)
ways to minimize the burden including
SUMMARY:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
70065
the use of automated collection
techniques or the use of other forms of
information technology; and (e) the
annual costs burden to respondents or
record keepers from the collection of
information (a total capital/startup costs
and operations and maintenance costs).
The comments that are submitted will
be summarized and included in the CBP
request for Office of Management and
Budget (OMB) approval. All comments
will become a matter of public record.
In this document CBP is soliciting
comments concerning the following
information collection:
Title: Customs Declaration.
OMB Number: 1651–0009.
Form Number: CBP Form 6059B.
Abstract: CBP Form 6059B, Customs
Declaration, is used as a standard report
of the identity and residence of each
person arriving in the United States.
This form is also used to declare
imported articles to U.S. Customs and
Border Protection (CBP) in accordance
with 19 U.S.C. 66 and section 498 of the
Tariff Act of 1930, as amended (19
U.S.C. 1498). Section 148.13 of the CBP
regulations prescribes the use of the
CBP Form 6059B when a written
declaration is required of a traveler
entering the United States. Generally,
written declarations are required from
travelers arriving by air or sea. Section
148.12 requires verbal declarations from
travelers entering the United States.
Generally, verbal declarations are
required from travelers arriving by land.
A sample of CBP Form 6059B can be
found at: https://www.cbp.gov/xp/cgov/
travel/vacation/sample_declaration_
form.xml
Current Actions: This submission is
being made to extend the expiration
date. In addition, burden hours have
been added to this collection to allow
for existing requirements for verbal
declarations under 19 CFR 148.12.
There are no changes to the data CBP
collects under the provisions of 19 CFR
148.12, 148.13 or CBP Form 6059B.
Type of Review: Extension (with
change).
Affected Public: Individuals.
CBP Form 6059B:
Estimated Number of Respondents:
105,606,000.
Estimated Number of Total Annual
Responses: 105,606,000.
Estimated Time per Response: 4
minutes.
Estimated Total Annual Burden
Hours: 7,075,602.
Verbal Declarations:
Estimated Number of Respondents:
233,000,000.
Estimated Number of Total Annual
Responses: 233,000,000.
Estimated Time per Response: 10
seconds.
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 78, Number 226 (Friday, November 22, 2013)]
[Notices]
[Page 70065]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28004]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Mucosal Environment and HIV
Prevention.
Date: December 17-18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, Chevy Chase
Ballroom, 4300 Military Road, NW, Washington, DC 20015.
Contact Person: Roberta Binder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, Room 3130, Bethesda, MD 20892-7616, 301-496-7966,
rbinder@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Innovation for HIV Vaccine
Discovery.
Date: December 18, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Sujata Vijh, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-
594-0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-28004 Filed 11-21-13; 8:45 am]
BILLING CODE 4140-01-P
